Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols.
Chondrocytes; Osteoarthritis; Inflammation; Polyphenols; Nrf2; Redox
Osteoarthritis (OA) is the most prevalent joint degenerative disease leading to irreversible structural and functional changes in the joint and is a major cause of disability and reduced life expectancy in ageing population. Despite the high prevalence of OA, there is no disease modifying drug available for the management of OA. Oxidative stress, a result of an imbalance between the production of reactive oxygen species (ROS) and their clearance by antioxidant defense system, is high in OA cartilage and is a major cause of chronic inflammation. Inflammatory mediators, such as interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) are highly upregulated in OA joints and induce ROS production and expression of matrix degrading proteases leading to cartilage extracellular matrix degradation and joint dysfunction. ROS and inflammation are interdependent, each being the target of other and represent ideal target/s for the treatment of OA. Plant polyphenols possess potent antioxidant and anti-inflammatory properties and can inhibit ROS production and inflammation in chondrocytes, cartilage explants and in animal models of OA. The aim of this review is to discuss the chondroprotective effects of polyphenols and modulation of different molecular pathways associated with OA pathogenesis and limitations and future prospects of polyphenols in OA treatment.
Ansari MY; Ahmad N; Haqqi TM
Biomedicine & Pharmacotherapy
2020
2020-07-03
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
journalArticle
<a href="http://doi.org/10.1016/j.biopha.2020.110452" target="_blank" rel="noreferrer noopener">10.1016/j.biopha.2020.110452</a>
Recent Findings And Future Directions In Breast Cancer Chemoprevention
Pharmacology & Pharmacy; Research & Experimental Medicine
Mamounas E P
Biomedicine & Pharmacotherapy
2005
2005-10
Journal Article or Conference Abstract Publication
<a href="http://doi.org/10.1016/s0753-3322(05)80067-8" target="_blank" rel="noreferrer noopener">10.1016/s0753-3322(05)80067-8</a>
Nsabp Adjuvant Trial On The Use Of Cox-2 Inhibition In Breast Cancer
Pharmacology & Pharmacy; Research & Experimental Medicine
Mamounas E P
Biomedicine & Pharmacotherapy
2005
2005-10
Journal Article or Conference Abstract Publication
<a href="http://doi.org/10.1016/s0753-3322(05)80060-5" target="_blank" rel="noreferrer noopener">10.1016/s0753-3322(05)80060-5</a>